MediWound Ltd.: Rosalind Advisors, Inc. amends Schedule 13G stake filing
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Rosalind Advisors, Inc. amended its Schedule 13G stake filing for MediWound Ltd., per SEC accession 0001622627-26-000029. The filing updates the investment adviser's reported position in the wound-care company, though the article did not disclose the revised share count or ownership percentage. Schedule 13G amendments are typically filed when a passive investor's stake crosses or moves past the 5% threshold or when previously reported holdings change materially. Investors will watch for the specific ownership figures in the amended filing to gauge Rosalind's current conviction in MediWound.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
Rosalind Advisors, Inc., MediWound Ltd.